Quantum Biopharma (QNTM) Other Non-Current Assets (2020 - 2026)

Quantum Biopharma (QNTM) has 6 years of Other Non-Current Assets data on file, last reported at $5.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 99.39% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 99.39% YoY), and the FY2025 full-year result was $2.2 million, up 157.02% from the prior year.
• Other Non-Current Assets grew to $5.5 million in Q1 2026, from $2.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $8.8 million in Q1 2022 to a low of $861230.0 in Q4 2024.
• A 4-year average of $4.3 million and a median of $5.1 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets increased 0.64% in 2022 and jumped 157.02% in 2025, its largest moves.
• Tracing QNTM's Other Non-Current Assets over 4 years: stood at $8.8 million in 2022, then sank by 90.18% to $861230.0 in 2024, then jumped by 157.02% to $2.2 million in 2025, then soared by 147.02% to $5.5 million in 2026.
• Business Quant data shows QNTM's Other Non-Current Assets at $5.5 million in Q1 2026, $2.2 million in Q4 2025, and $5.2 million in Q3 2025.